{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:13:10Z","timestamp":1790007190086,"version":"4.0.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.vaccine.2024.01.099","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T20:14:17Z","timestamp":1707768857000},"page":"2212-2219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Acute disseminated encephalomyelitis and transverse myelitis following COVID-19 vaccination \u2013 A self-controlled case series analysis"],"prefix":"10.1016","volume":"42","author":[{"given":"Hannah J.","family":"Morgan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel J.","family":"Clothier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Sepulveda Kattan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim P.","family":"Buttery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.vaccine.2024.01.099_b0005","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1542\/pir.2019-0179","article-title":"Acute transverse myelitis and acute disseminated encephalomyelitis","volume":"41","author":"Kahn","year":"2020","journal-title":"Pediatr Rev"},{"issue":"11","key":"10.1016\/j.vaccine.2024.01.099_b0010","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archneur.62.11.1673","article-title":"Acute disseminated encephalomyelitis: an update","volume":"62","author":"Menge","year":"2005","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.01.099_b0015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ncl.2012.09.008","article-title":"Transverse myelitis","volume":"31","author":"Beh","year":"2013","journal-title":"Neurol Clin"},{"issue":"6","key":"10.1016\/j.vaccine.2024.01.099_b0020","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMcp1001112","article-title":"Clinical practice. transverse myelitis","volume":"363","author":"Frohman","year":"2010","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.vaccine.2024.01.099_b0025","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1080\/21645515.2021.1901544","article-title":"Acute disseminated encephalomyelitis and routine childhood vaccinations \u2013 a self-controlled case series","volume":"17","author":"Martin","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"10.1016\/j.vaccine.2024.01.099_b0030","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/cid\/ciw607","article-title":"Acute demyelinating events following vaccines: a case-centered analysis","volume":"63","author":"Baxter","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.01.099_b0035","unstructured":"World Health Organization. WHO COVID-19 Dashboard Geneva2020 [22\/11\/2023]. Available from: https:\/\/covid19.who.int\/."},{"issue":"42","key":"10.1016\/j.vaccine.2024.01.099_b0040","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.1016\/j.vaccine.2023.08.079","article-title":"Background rates of adverse events of special interest for COVID-19 vaccines: a multinational Global Vaccine Data Network (GVDN) analysis","volume":"41","author":"Phillips","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.01.099_b0045","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jocn.2023.03.008","article-title":"Acute disseminated encephalomyelitis (ADEM) following COVID-19 vaccination: a systematic review","volume":"111","author":"Nabizadeh","year":"2023","journal-title":"Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia"},{"key":"10.1016\/j.vaccine.2024.01.099_b0050","doi-asserted-by":"crossref","unstructured":"Stoian A, Bajko Z, Stoian M, Cioflinc RA, Niculescu R, Arb\u0103na\u0219i EM, et al. The Occurrence of Acute Disseminated Encephalomyelitis in SARS-CoV-2 Infection\/Vaccination: Our Experience and a Systematic Review of the Literature. 2023;11(7):1225.","DOI":"10.3390\/vaccines11071225"},{"key":"10.1016\/j.vaccine.2024.01.099_b0055","unstructured":"Global Vaccine Data Network. About 2023 [Available from: https:\/\/www.globalvaccinedatanetwork.org\/."},{"key":"10.1016\/j.vaccine.2024.01.099_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.01.025","article-title":"What would have happened anyway? Population data source considerations when estimating background incident rates of adverse events following immunisation to inform vaccine safety","author":"Clothier","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.01.099_b0065","unstructured":"Centre for Health Analytics. Vaccine Safety Health Link (VSHL) 2021 [Available from: https:\/\/www.healthanalytics.org.au\/directory\/vshl\/."},{"key":"10.1016\/j.vaccine.2024.01.099_b0070","unstructured":"Department of Health and Aged Care. Using the Australian Immunisation Register 2023 [Available from: https:\/\/www.health.gov.au\/topics\/immunisation\/immunisation-information-for-health-professionals\/using-the-australian-immunisation-register."},{"key":"10.1016\/j.vaccine.2024.01.099_b0075","unstructured":"Department of Health. Victorian Admitted Episodes Dataset (VAED) manual 2023-2024 2023 [Available from: https:\/\/www.health.vic.gov.au\/publications\/victorian-admitted-episodes-dataset-vaed-manual-2023-2024."},{"key":"10.1016\/j.vaccine.2024.01.099_b0080","doi-asserted-by":"crossref","unstructured":"Petersen I, Douglas I, Whitaker HJb. Self controlled case series methods: an alternative to standard epidemiological study designs. 2016;354.","DOI":"10.1136\/bmj.i4515"},{"issue":"1","key":"10.1016\/j.vaccine.2024.01.099_b0085","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.vaccine.2012.07.024","article-title":"Biologically plausible and evidence-based risk intervals in immunization safety research","volume":"31","author":"Rowhani-Rahbar","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.01.099_b0090","unstructured":"Weldeselassie YGW, Heather; Farrington, Paddy. SCCS: The Self-Controlled Case Series Method. 1.6 ed2022."},{"key":"10.1016\/j.vaccine.2024.01.099_b0095","unstructured":"Department of Health and Aged Care. COVID-19 2023 [Available from: https:\/\/immunisationhandbook.health.gov.au\/contents\/vaccine-preventable-diseases\/covid-19."},{"key":"10.1016\/j.vaccine.2024.01.099_b0100","unstructured":"ATAGI statement on revised recommendations on the use of COVID-19 Vaccine AstraZeneca, 17 June 2021 [press release]. 2021."},{"issue":"1","key":"10.1016\/j.vaccine.2024.01.099_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14760584.2023.2143347","article-title":"Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic","volume":"22","author":"Solante","year":"2023","journal-title":"Expert Rev Vaccines"},{"issue":"9","key":"10.1016\/j.vaccine.2024.01.099_b0110","doi-asserted-by":"crossref","first-page":"e061752","DOI":"10.1136\/bmjopen-2022-061752","article-title":"Estimating deaths averted and cost per life saved by scaling up mRNA COVID-19 vaccination in low-income and lower-middle-income countries in the COVID-19 Omicron variant era: a modelling study","volume":"12","author":"Alexandra","year":"2022","journal-title":"BMJ Open"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24001269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24001269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T19:29:47Z","timestamp":1723058987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24001269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0264410X24001269"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.01.099","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute disseminated encephalomyelitis and transverse myelitis following COVID-19 vaccination \u2013 A self-controlled case series analysis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.01.099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}